- Home
- DD vs LH Comparison
DD vs LH Comparison
Compare DD & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DD | LH |
|---|---|---|
| Founded | 2015 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 20.9B |
| IPO Year | 2016 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DD | LH |
|---|---|---|
| Price | $50.41 | $282.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $62.07 | ★ $305.73 |
| AVG Volume (30 Days) | ★ 4.9M | 698.1K |
| Earning Date | 05-12-2026 | 05-20-2026 |
| Dividend Yield | ★ 1.59% | 1.02% |
| EPS Growth | N/A | ★ 85.32 |
| EPS | N/A | ★ 8.48 |
| Revenue | ★ $20,397,000,000.00 | $13,008,900,000.00 |
| Revenue This Year | $6.91 | $8.00 |
| Revenue Next Year | $3.82 | $4.94 |
| P/E Ratio | ★ N/A | $33.23 |
| Revenue Growth | N/A | ★ 6.97 |
| 52 Week Low | $33.34 | $209.38 |
| 52 Week High | $83.40 | $293.72 |
Technical Indicators
Market Signals| Indicator | DD | LH |
|---|---|---|
| Relative Strength Index (RSI) | 62.77 | 58.90 |
| Support Level | $48.90 | $260.57 |
| Resistance Level | $51.99 | $292.02 |
| Average True Range (ATR) | 1.54 | 7.63 |
| MACD | 0.27 | -0.03 |
| Stochastic Oscillator | 71.66 | 69.38 |
Price Performance
Historical ComparisonAbout DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.